Fucoidan in cancer therapy: from biomedical application to medicinal chemistry approach
Zheng Y., Fang S., Liu N., Zhang T., Huang Y., Li L.
Narrative Review on Chronic Inflammation, Immune Modulation, published in J Mater Sci Mater Med (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- J Mater Sci Mater Med (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41343091
- PMCID
- PMC12689777
- DOI
- 10.1007/s10856-025-06962-8
- Citations
- 4
Abstract (original English)
Biomaterials based on carbohydrate polymers, particularly modified polysaccharides, are gaining attention for cancer treatment due to their diverse properties and performance in clinical applications. While research on polysaccharides like chitosan and alginate is abundant, studies on chemically functionalized derivatives are limited. These derivatives, such as fucoidan, sulfated polysaccharides from brown seaweeds, offer minimal side effects and suitable drug release profiles. Fucoidan exhibits various biological activities, including anticancer, anti-inflammatory, and immunomodulatory effects, making it a promising candidate for cancer diagnosis and therapy. This review is the first to comprehensively explore the applications of fucoidan in combating cancer, focusing on its ability to inhibit tumor growth, induce cell death, and modify the tumor microenvironment. Additionally, the review discusses nanostructured chemically modified fucoidan-based biomaterials, which show potential for hydrogel engineering and enhanced drug delivery systems. These advancements highlight the significance of chemical modifications and mechanistic insights into targeted drug delivery and controlled release rates. Incorporating fucoidan into nanocarriers improves its biodegradability, biocompatibility, and structural stability, facilitating surface modifications that enhance targeting efficiency a
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Comparing Regenerative Biologics and Standard Pharmacotherapy for Chronic Rotator Cuff Tendinopathy: A Study of PRP, Cell-Based, and Peptide Interventions
Systematic Review on Tendon Injury, Rotator Cuff, Shoulder Pain, Chronic Inflammation, published in J Orthop Sports Med (2026) — summary generated from the PubMed abstract.
- 2026
J Orthop Sports Med - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol - Level AMeta-analysisPubMed
Comparative efficacy of different doses of mesenchymal stem cells derived from different tissue sources for knee osteoarthritis: a systematic review and network meta-analysis of randomized controlled trials.
Meta-analysis with a reported sample of 602 on Knee Osteoarthritis, Osteoarthritis, Chronic Inflammation, Immune Modulation, published in PeerJ (2026) — summary generated from the PubMed abstract.
- 2026
- n = 602
PeerJ - Level ASystematic ReviewEurope PMC
Exosomes as Cellular Communicators and Therapeutic Agents in Orthopedic Diseases: From Mechanisms to Intervention
Systematic Review on Osteoarthritis, Chronic Inflammation, published in Int J Nanomedicine (2026) — summary generated from the PubMed abstract.
- 2026
Int J Nanomedicine1 citations - Level ASystematic ReviewEurope PMC
Pharmacotherapy agents in prevention and treatment of breast cancer-related lymphedema: a systematic scoping review
Systematic Review on Chronic Inflammation, Immune Modulation, published in Front Oncol (2026) — summary generated from the PubMed abstract.
- 2026
Front Oncol - Level ASystematic ReviewEurope PMC
Trends in peripheral nerve injury research: a bibliometric analysis focused on molecular mechanisms
Systematic Review on Chronic Inflammation, published in Front Neurol (2026) — summary generated from the PubMed abstract.
- 2026
Front Neurol